ACC.26 advanced registration ends Feb. 12 – register now!

Megan Coylewright, MD, MPH, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boston Scientific(SIGNIFICANT), Alleviant(SIGNIFICANT), Edwards LifeSciences(SIGNIFICANT), Medtronic(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Abbott(NONE)

View Full Disclosure